Stage IIIA Breast Cancer Recruiting Phase 1 / 2 Trials for Triciribine (DB12405)

IndicationStatusPhase
DBCOND0028774 (Stage IIIA Breast Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01697293Triciribine Phosphate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerTreatment